Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_assertion type Assertion NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_head.
- NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_provenance.
- NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_assertion evidence source_evidence_literature NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_provenance.
- NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_assertion SIO_000772 17617024 NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_provenance.
- NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_assertion wasDerivedFrom befree-2016 NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_provenance.
- NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_assertion wasGeneratedBy ECO_0000203 NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_provenance.